Free Trial
NYSE:INFU

InfuSystem 11/7/2024 Earnings Report

InfuSystem logo
$5.70 +0.10 (+1.79%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.70 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InfuSystem EPS Results

Actual EPS
$0.08
Consensus EPS
$0.08
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

InfuSystem Revenue Results

Actual Revenue
$35.32 million
Expected Revenue
$35.50 million
Beat/Miss
Missed by -$180.00 thousand
YoY Revenue Growth
N/A

InfuSystem Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

InfuSystem Earnings Headlines

Roth Capital Predicts InfuSystem's Q2 Earnings (NYSE:INFU)
Too busy to trade? Good.
Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at screens all day. Just enter near the close, exit the next morning—and move on. Some trades have hit 200%+ overnight.
InfuSystem (NYSE:INFU) Now Covered by Analysts at Roth Capital
InfuSystem: Investments Are Starting To Pay Off
See More InfuSystem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like InfuSystem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InfuSystem and other key companies, straight to your email.

About InfuSystem

InfuSystem (NYSE:INFU), through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

View InfuSystem Profile

More Earnings Resources from MarketBeat